ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES OF U-90152 AND U-75875 IN HUMAN BRAIN-CELL CULTURES

被引:4
|
作者
PETERSON, PK
GEKKER, G
HU, SX
CHAO, CC
机构
[1] MINNEAPOLIS MED RES FDN INC,NEUROIMMUNOBIOL & HOST DEF LAB,MINNEAPOLIS,MN
[2] UNIV MINNESOTA,SCH MED,MINNEAPOLIS,MN 55455
关键词
D O I
10.1128/AAC.38.10.2465
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antiviral activities of the reverse transcriptase inhibitors U-90152 and 3'-azido-2',3'-dideoxythymidine and the protease inhibitor U-75875 were compared in two culture models of human immunodeficiency virus type 1 brain infection. In a model involving acutely infected microglial cells, U-90152 was the most active, whereas in a model using chronically infected promonocytes, U-75875 was the most active.
引用
收藏
页码:2465 / 2468
页数:4
相关论文
共 50 条
  • [1] IN-VITRO INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY A COMBINATION OF DELAVIRDINE (U-90152) WITH PROTEASE INHIBITOR U-75875 OR INTERFERON-ALPHA
    PAGANO, PJ
    CHONG, KT
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01): : 61 - 67
  • [2] U-90152, A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    DUEWEKE, TJ
    POPPE, SM
    ROMERO, DL
    SWANEY, SM
    SO, AG
    DOWNEY, KM
    ALTHAUS, IW
    REUSSER, F
    BUSSO, M
    RESNICK, L
    MAYERS, DI
    LANE, J
    ARISTOFF, PA
    THOMAS, RC
    TARPLEY, WG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) : 1127 - 1131
  • [3] ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES OF NOVEL NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS
    NOTTET, HSLM
    OTEMAN, MHT
    VISSER, MR
    VERHOEF, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (02) : 366 - 368
  • [4] SYNTHESIS AND ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES OF NEW PEPTIDO-NUCLEOSIDE ANALOGS
    CAMPLO, M
    NIDDAM, V
    BARHTELEMY, P
    FAURY, P
    MOURIER, N
    SIMON, V
    CHARVET, AS
    TRABAUD, C
    GRACIET, JC
    CHERMANN, JC
    KRAUS, JL
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 (10) : 789 - 800
  • [5] ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES AND PHARMACOKINETICS OF NOVEL 6-SUBSTITUTED ACYCLOURIDINE DERIVATIVES
    BABA, M
    DECLERCO, E
    IIDA, S
    TANAKA, H
    NITTA, I
    UBASAWA, M
    TAKASHIMA, H
    SEKIYA, K
    UMEZU, K
    NAKASHIMA, H
    SHIGETA, S
    WALKER, RT
    MIYASAKA, T
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) : 2358 - 2363
  • [6] SYNTHESIS OF SULFATED CEREBROSIDE ANALOGS HAVING MIMICS OF CERAMIDE AND THEIR ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES
    YOSHIDA, H
    IKEDA, K
    ACHIWA, K
    HOSHINO, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1995, 43 (04) : 594 - 602
  • [7] INVITRO ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY OF BILIVERDIN, A BILE PIGMENT
    MORI, H
    OTAKE, T
    MORIMOTO, M
    UEBA, N
    KUNITA, N
    NAKAGAMI, T
    YAMASAKI, N
    TAJI, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (07): : 755 - 757
  • [8] ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY OF HYDROXYUREA IN COMBINATION WITH 2',3'-DIDEOXYNUCLEOSIDES
    GAO, WY
    JOHNS, DG
    MITSUYA, H
    MOLECULAR PHARMACOLOGY, 1994, 46 (04) : 767 - 772
  • [9] A NOVEL ASSAY SYSTEM FOR ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ACTIVITY USING A SUBCLONE OF A MONOCYTIC CELL-LINE, U937
    MIYANOKUROSAKI, N
    NAKASHIMA, H
    ICHIYAMA, K
    INAZAWA, K
    TABATA, H
    TANABE, H
    OHNISHI, K
    MIZUSAWA, H
    OHSHIRO, Y
    YAMAMOTO, N
    MICROBIOLOGY AND IMMUNOLOGY, 1994, 38 (10) : 813 - 818
  • [10] GANCICLOVIR ANTAGONIZES THE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY OF ZIDOVUDINE AND DIDANOSINE INVITRO
    MEDINA, DJ
    HSIUNG, GD
    MELLORS, JW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) : 1127 - 1130